Fabio Arcidiacono

470 total citations
26 papers, 199 citations indexed

About

Fabio Arcidiacono is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Fabio Arcidiacono has authored 26 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 6 papers in Surgery. Recurrent topics in Fabio Arcidiacono's work include Advanced Radiotherapy Techniques (8 papers), Brain Metastases and Treatment (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Fabio Arcidiacono is often cited by papers focused on Advanced Radiotherapy Techniques (8 papers), Brain Metastases and Treatment (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Fabio Arcidiacono collaborates with scholars based in Italy, United States and Malaysia. Fabio Arcidiacono's co-authors include Ernesto Maranzano, Fabio Trippa, Paola Anselmo, Michelina Casale, Gianluca Ingrosso, Riccardo Santoni, Elisabetta Ponti, Alessandra Carosi, Andrea Lancia and Cynthia Aristei and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and British Journal of Radiology.

In The Last Decade

Fabio Arcidiacono

23 papers receiving 199 citations

Peers

Fabio Arcidiacono
Fabio Arcidiacono
Citations per year, relative to Fabio Arcidiacono Fabio Arcidiacono (= 1×) peers Pierre Auberdiac

Countries citing papers authored by Fabio Arcidiacono

Since Specialization
Citations

This map shows the geographic impact of Fabio Arcidiacono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Arcidiacono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Arcidiacono more than expected).

Fields of papers citing papers by Fabio Arcidiacono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Arcidiacono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Arcidiacono. The network helps show where Fabio Arcidiacono may publish in the future.

Co-authorship network of co-authors of Fabio Arcidiacono

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Arcidiacono. A scholar is included among the top collaborators of Fabio Arcidiacono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Arcidiacono. Fabio Arcidiacono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gili, Alessio, Annalisa Guida, Fabio Arcidiacono, et al.. (2025). Fast-Track Diagnostic Pathway for Lung Cancer Detection: Single-Center Experience. Journal of Clinical Medicine. 14(9). 2915–2915.
2.
Viani, Gustavo Arruda, Alexander V. Louie, Fabio Arcidiacono, et al.. (2024). Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis. Radiotherapy and Oncology. 201. 110439–110439. 2 indexed citations
3.
Pergolizzi, Stefano, Alberto Cacciola, Silvana Parisi, et al.. (2022). An Italian survey on “palliative intent” radiotherapy. Reports of Practical Oncology & Radiotherapy. 27(3). 419–427. 6 indexed citations
4.
Arcidiacono, Fabio, Paola Anselmo, Michelina Casale, et al.. (2022). STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 115(4). 886–896. 6 indexed citations
5.
Trippa, Fabio, et al.. (2020). Long-term palliation of lymph node oligometastatic ovarian carcinoma after repeated stereotactic body radiotherapy: case report. Tumori Journal. 106(6). NP63–NP66. 2 indexed citations
6.
Maranzano, Ernesto, Michelina Casale, Rossella Rispoli, et al.. (2020). LINAC-based radiosurgery for melanoma, sarcoma and renal cell carcinoma brain metastases. Journal of Neurosurgical Sciences. 64(1). 37–43. 3 indexed citations
7.
Arcidiacono, Fabio, Paola Anselmo, Fabio Trippa, et al.. (2020). PO-1021: Stereotactic radiotherapy for unresectable locally advanced non small cell lung cancer. Radiotherapy and Oncology. 152. S545–S545. 1 indexed citations
8.
Vicenzi, Lisa, Fabio Trippa, Fabio Arcidiacono, et al.. (2019). Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach. La radiologia medica. 124(9). 819–825. 3 indexed citations
9.
Anselmo, Paola, Michelina Casale, Fabio Arcidiacono, et al.. (2019). Twelve-year results of LINAC-based radiosurgery for vestibular schwannomas. Strahlentherapie und Onkologie. 196(1). 40–47. 6 indexed citations
10.
Maranzano, Ernesto, et al.. (2019). Accelerated partial-breast irradiation with high-dose-rate brachytherapy: Mature results of a Phase II trial. Brachytherapy. 18(5). 627–634. 1 indexed citations
11.
Maranzano, Ernesto, et al.. (2019). A prospective phase II trial on reirradiation of brain metastases with radiosurgery. Clinical and Translational Radiation Oncology. 17. 1–6. 8 indexed citations
12.
Maranzano, Ernesto, et al.. (2017). Definitive three-dimensional high-dose-rate brachytherapy for inoperable endometrial cancer. Journal of Contemporary Brachytherapy. 2(2). 118–123. 14 indexed citations
13.
Aristei, Cynthia, Ernesto Maranzano, Valentina Lancellotta, et al.. (2017). Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study. Radiotherapy and Oncology. 124(2). 208–213. 24 indexed citations
14.
Trippa, Fabio, et al.. (2016). Stereotactic Body Radiotherapy for Lymph Node Relapse in Ovarian Cancer. 1(1). 6 indexed citations
15.
Sanguineti, Giuseppe, Fabio Arcidiacono, Valeria Landoni, et al.. (2016). Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study. International Journal of Radiation Oncology*Biology*Physics. 96(2). 304–312. 16 indexed citations
16.
Ingrosso, Gianluca, Fabio Trippa, Ernesto Maranzano, et al.. (2016). Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience. World Journal of Urology. 35(1). 45–49. 56 indexed citations
17.
Maranzano, Ernesto, Michelina Casale, Fabio Arcidiacono, et al.. (2015). Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas. Strahlentherapie und Onkologie. 191(12). 953–960. 13 indexed citations
18.
Bellavita, Rita, Vittorio Bini, Fabio Arcidiacono, et al.. (2015). Radiotherapy for Early-Stage Prostate Cancer in Men under 70 Years of Age. Tumori Journal. 102(2). 209–216. 5 indexed citations
19.
Falcinelli, Lorenzo, Isabella Palumbo, Fabio Arcidiacono, et al.. (2015). Prostate cancer: contouring target and organs at risk by kilovoltage and megavoltage CT and MRI in patients with and without hip prostheses. British Journal of Radiology. 88(1056). 20150509–20150509. 3 indexed citations
20.
Arcidiacono, Fabio. (2015). Avoiding CRUD operations lock-in in NoSQL databases : extension of the CPIM library. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026